OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes
Harpreet S. Bajaj, Ronald Goldenberg
touchREVIEWS in Endocrinology (2023) Vol. 19, Iss. 1, pp. 4-4
Open Access | Times Cited: 13

Showing 13 citing articles:

Endocrinology: What You May Have Missed in 2024
Mohamed Aman, Athavi Jeevananthan, Maria Martinez-Cruz, et al.
Annals of Internal Medicine (2025)
Closed Access | Times Cited: 1

Perioperative and periprocedural management of once-weekly insulin treated patients
Robyn L. Houlden, Jeremy Gilbert, Tayyab Khan, et al.
Endocrine Practice (2025)
Closed Access

Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus
David Q. Pham, John Andraos, Joelle Ayoub
Reviews in Endocrine and Metabolic Disorders (2025)
Open Access

Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies
Ken Munene Nkonge, Dennis Karani Nkonge, Teresa Njeri Nkonge
Diabetes Therapy (2023) Vol. 14, Iss. 11, pp. 1801-1831
Open Access | Times Cited: 9

Efficacy and safety of once-weekly insulin icodec compared to once-daily insulin g U-100 in patients with type II diabetes: a systematic review and meta-analysis
Syed Zia Saleem, Areeba Fareed, Syed Muhammad Muneeb Akhtar, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Once-weekly Insulin Icodec Versus Once-daily Long-acting Insulin for Type II Diabetes: A Meta-analysis of Randomized Controlled Trials
Mohamed Abuelazm, Ahmed A. Ibrahim, Yehya Khlidj, et al.
Journal of the Endocrine Society (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 5

Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review
Julio Rosenstock, Harpreet S. Bajaj, Ildiko Lingvay, et al.
BMJ Open Diabetes Research & Care (2024) Vol. 12, Iss. 3, pp. e003930-e003930
Open Access | Times Cited: 1

Insulin Icodec: A Silver Lining to the Diabetic Cloud
Meenu Thomas, Prithpal Singh Matreja, J S Prakash, et al.
International Journal of Human and Health Sciences (IJHHS) (2024) Vol. 8, Iss. 1, pp. 15-15
Open Access

Icodec: A Novel Once-Weekly Basal Insulin for Diabetes Management
Jennifer D. Goldman, Curtis Triplitt, Diana Isaacs
Annals of Pharmacotherapy (2024)
Open Access

Evaluation of an inpatient automatic dose reduction protocol for concentrated insulin glargine upon therapeutic interchange to insulin detemir on hypoglycemia rates
Janci Addison, Brittany Glowacki, Denise Kelley, et al.
American Journal of Health-System Pharmacy (2024)
Closed Access

Page 1

Scroll to top